← Back to Search

Behavioural Intervention

Pharmacy-Based STBBI Testing for HIV, Hepatitis C, and Syphilis

N/A
Waitlist Available
Research Sponsored by Memorial University of Newfoundland
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ages 18 years and older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial will assess the impact of a pharmacy-based testing program for HIV, hepatitis C, and syphilis in participating pharmacies in three Canadian provinces.

Who is the study for?
The APPROACH 2.0 study is for English-speaking adults (18+) in Canada with a provincial health card who can consent to participate. It's not for those already diagnosed with HIV or HCV, but they may still get certain tests.
What is being tested?
This trial offers pharmacy-based testing for HIV, hepatitis C, and syphilis using point of care tests or dry blood spot tests. The goal is to see if this approach helps find new cases and connect people to care.
What are the potential side effects?
There are no direct side effects from participating as it involves non-invasive testing procedures. However, there might be emotional or psychological impacts due to the results of the STBBI tests.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Participants requesting test(s) for HIV, HCV, and/or syphilisExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Memorial University of NewfoundlandLead Sponsor
71 Previous Clinical Trials
1,835,582 Total Patients Enrolled

Media Library

Choice of STBBI test(s) (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05534633 — N/A
Human Immunodeficiency Virus Infection Research Study Groups: Participants requesting test(s) for HIV, HCV, and/or syphilis
Human Immunodeficiency Virus Infection Clinical Trial 2023: Choice of STBBI test(s) Highlights & Side Effects. Trial Name: NCT05534633 — N/A
Choice of STBBI test(s) (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05534633 — N/A
~136 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top